indirectly dealing in Active Pharmaceutical Ingredient (API), Pharmaceutical products, or formulation containing Vildagliptin alone or Vildagliptin in combination with any other compound ... stock of infringing pharmaceutical formulations, compound of combinations comprising Vildagliptin alone and/or Vidagliptin in combination with any other compound or formulation available with
Page 1 of 4
C/AO/189/2015 ORDER
formulation containing Vildagliptin exclusively or with
Metformin Hydrochloride in combination or Vildagliptin in
combination with ... exporting, directly or indirectly,
dealing in pharmaceutical products component or
formulation containing Vildagliptin alone or
Vildagliptin + Metformin Hydrochloride in
combination or Vildagliptin in combination with
product and New Chemical Entity (NCE), assigned International Non-Proprietary Name (INN) Vildagliptin. The petitioner is said to operate in India through its subsidiary which ... markets patented product Vildagliptin in India. The petitioner claims to have spent substantial financial resources on pharmaceutical research and development in order to invent
